Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Althera Laboratories
Morristown, New Jersey, United Statesaltherapharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Althera Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of cardiovascular therapies. The company's lead product is Roszet, a fixed-dose combination of rosuvastatin and ezetimibe, which was approved by the FDA in 2021 for the treatment of hyperlipidemia. Althera aims to improve patient outcomes by providing convenient combination treatments that address high cholesterol through multiple mechanisms of action. The company operates primarily in the United States and targets the large market for lipid-lowering medications.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Althera Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Althera Laboratories.